Stejbach Mark — SEC Form 4 Insider Trading Activity

Summary

Updated Jul 16, 2026

Stejbach Mark has filed 1 SEC Form 4 filing across 1 company in the last 90 days.

Profile

Mark Stejbach is identified as a director of Indivior Pharmaceuticals, Inc. in the SEC filing dated 2026-01-28 (CIK 0001487937). The filing indicates he has no reported purchases or sales. Indivior Pharmaceuticals is described as a specialty pharmaceutical company focused on opioid use disorder, and Stejbach serves in a governance role for the company.

Board memberships

• Indivior Pharmaceuticals, Inc.

Awards & honors

• Governs Indivior Pharmaceuticals, Inc. as a board director
• Provides governance oversight and fiduciary guidance in alignment with company strategy

Recent Transactions

Companies — Last 90 Days

• Indivior Pharmaceuticals, Inc. (INDV) — 1 filings, last 2026-05-14

Frequently Asked Questions

Who is Stejbach Mark?

Mark Stejbach is identified as a director of Indivior Pharmaceuticals, Inc. in the SEC filing dated 2026-01-28 (CIK 0001487937). The filing indicates he has no reported purchases or sales. Indivior Pharmaceuticals is described as a specialty pharmaceutical company focused on opioid use disorder, and Stejbach serves in a governance role for the company.…

How many SEC Form 4 filings has Stejbach Mark submitted recently?

1 primary Form 4 filings in the last 90 days, covering 1 company.

Where can I see all of Stejbach Mark's SEC filings?

All Form 4 filings, transaction values, and 10b5-1 plan flags are listed on this page and updated in real time as new SEC EDGAR filings are processed.

Learn More

• What is SEC Form 4?
• How to read insider buying signals
• Understanding Rule 10b5-1 trading plans
• Browse all insiders
• Most active insiders this week